safrole has been researched along with mart-1 antigen in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhuri, A; Meka, RR; Mukherjee, S; Patra, CR | 1 |
1 other study(ies) available for safrole and mart-1 antigen
| Article | Year |
|---|---|
Shikimoyl-ligand decorated gold nanoparticles for use in ex vivo engineered dendritic cell based DNA vaccination.
Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Cell Survival; Dendritic Cells; Female; Gold; Immunity, Cellular; Interferon-gamma; Ligands; MART-1 Antigen; Melanoma, Experimental; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Nanostructures; Plasmids; Safrole; Survival Rate; Transplantation, Homologous | 2019 |